Galiximab

From Ganfyd

Jump to: navigation, search

Humanised monoclonal antibody against CD80, a co-stimulatory molecule found transiently on some normal lymphocytes, but also expressed by certain B-cell lymphomas. Following promising initial studies,[1][2] it is currently undergoing phase III trials in the treatment of certain types of relapsed B-cell lymphomas.

References